AKCA
Transfer...
 Symbol:
NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Distressed
# of Employee: 100 / Fiscal Year End: 2018-12-31 / Stock Type: —
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.

Competitors

Competitors List | Company Detail

AKCA |

Finance Benchmark

Key Ratio Benchmark | Key Ratio B | Income B | Balance B | Cash B | Top

ROE

ReportDatePeriodType(AKCA)(AKCA)

ROE Trend

ReportDatePeriodType(AKCA)(AKCA)

FCFMargin

ReportDatePeriodType(AKCA)(AKCA)

FCFMargin Trend

ReportDatePeriodType(AKCA)(AKCA)

FCFPerShare

ReportDatePeriodType(AKCA)(AKCA)

FCFPerShare Trend

ReportDatePeriodType(AKCA)(AKCA)

EquityPerShare

ReportDatePeriodType(AKCA)(AKCA)

EquityPerShare Trend

ReportDatePeriodType(AKCA)(AKCA)

Income Statement Benchmark | Key Ratio B | Income B | Balance B | Cash B | Top

Revenue

ReportDatePeriodType(AKCA)(AKCA)
2017-03-25Quarter9,597k
2017-06-25Quarter14,128k
2017-09-25Quarter13,449k
2017-12-25Quarter18,036k
2018-03-25Quarter17,108k
2018-06-25Quarter18,321k
2018-09-25Quarter19,241k
2018-12-25Quarter10,197k
2019-03-25Quarter163,816k

Revenue Trend

ReportDatePeriodType(AKCA)(AKCA)
2018-03-25Quarter78.26%
2018-06-25Quarter29.68%
2018-09-25Quarter43.07%
2018-12-25Quarter-43.46%
2019-03-25Quarter857.54%

ContinuousOperatingIncome

ReportDatePeriodType(AKCA)(AKCA)
2017-03-25Quarter-60,353k
2017-06-25Quarter-11,944k
2017-09-25Quarter-14,094k
2017-12-25Quarter-23,361k
2018-03-25Quarter-29,627k
2018-06-25Quarter-62,046k
2018-09-25Quarter-63,591k
2018-12-25Quarter-70,557k
2019-03-25Quarter27,187k

ContinuousOperatingIncome Trend

ReportDatePeriodType(AKCA)(AKCA)
2018-03-25Quarter-50.91%
2018-06-25Quarter419.47%
2018-09-25Quarter351.19%
2018-12-25Quarter202.03%
2019-03-25Quarter-191.76%

NetIncome

ReportDatePeriodType(AKCA)(AKCA)
2017-03-25Quarter-60,353k
2017-06-25Quarter-11,944k
2017-09-25Quarter-14,094k
2017-12-25Quarter-23,361k
2018-03-25Quarter-29,627k
2018-06-25Quarter-62,046k
2018-09-25Quarter-63,591k
2018-12-25Quarter-70,557k
2019-03-25Quarter27,187k

NetIncome Trend

ReportDatePeriodType(AKCA)(AKCA)
2018-03-25Quarter-50.91%
2018-06-25Quarter419.47%
2018-09-25Quarter351.19%
2018-12-25Quarter202.03%
2019-03-25Quarter-191.76%

DilutedShares

ReportDatePeriodType(AKCA)(AKCA)
2017-03-25Quarter28,884,540.0
2017-06-25Quarter50,593,340.0
2017-09-25Quarter53,522,615.0
2017-12-25Quarter66,541,629.0
2018-03-25Quarter66,616,337.0
2018-06-25Quarter60,832,494.0
2018-09-25Quarter87,209,882.0
2018-12-25Quarter89,083,148.0
2019-03-25Quarter94,127,942.0

DilutedShares Trend

ReportDatePeriodType(AKCA)(AKCA)
2018-03-25Quarter130.63%
2018-06-25Quarter20.24%
2018-09-25Quarter62.94%
2018-12-25Quarter33.88%
2019-03-25Quarter41.30%

ProfitMargin

ReportDatePeriodType(AKCA)(AKCA)
2017-03-25Quarter100.00%
2017-06-25Quarter100.00%
2017-09-25Quarter100.00%
2017-12-25Quarter100.00%
2018-03-25Quarter100.00%
2018-06-25Quarter-115.40%
2018-09-25Quarter53.50%
2018-12-25Quarter72.60%
2019-03-25Quarter98.50%

ProfitMargin Trend

ReportDatePeriodType(AKCA)(AKCA)
2018-03-25Quarter0.00%
2018-06-25Quarter-215.40%
2018-09-25Quarter-46.50%
2018-12-25Quarter-27.40%
2019-03-25Quarter-1.50%

ContinuousNetMargin

ReportDatePeriodType(AKCA)(AKCA)
2017-03-25Quarter-628.90%
2017-06-25Quarter-84.50%
2017-09-25Quarter-104.80%
2017-12-25Quarter-129.50%
2018-03-25Quarter-173.20%
2018-06-25Quarter-338.70%
2018-09-25Quarter-330.50%
2018-12-25Quarter-691.90%
2019-03-25Quarter16.60%

ContinuousNetMargin Trend

ReportDatePeriodType(AKCA)(AKCA)
2018-03-25Quarter-72.46%
2018-06-25Quarter300.83%
2018-09-25Quarter215.36%
2018-12-25Quarter434.29%
2019-03-25Quarter-109.58%

NetMargin

ReportDatePeriodType(AKCA)(AKCA)
2017-03-25Quarter-628.90%
2017-06-25Quarter-84.50%
2017-09-25Quarter-104.80%
2017-12-25Quarter-129.50%
2018-03-25Quarter-173.20%
2018-06-25Quarter-338.70%
2018-09-25Quarter-330.50%
2018-12-25Quarter-691.90%
2019-03-25Quarter16.60%

NetMargin Trend

ReportDatePeriodType(AKCA)(AKCA)
2018-03-25Quarter-72.46%
2018-06-25Quarter300.83%
2018-09-25Quarter215.36%
2018-12-25Quarter434.29%
2019-03-25Quarter-109.58%

Balance Sheet Benchmark | Key Ratio B | Income B | Balance B | Cash B | Top

Equity

ReportDatePeriodType(AKCA)(AKCA)
2016-12-25Quarter-17,747k
2017-03-25Quarter-74,942k
2017-06-25Quarter-82,983k
2017-09-25Quarter197,843k
2017-12-25Quarter179,633k
2018-03-25Quarter146,300k
2018-06-25Quarter290,404k
2018-09-25Quarter281,411k
2018-12-25Quarter276,724k
2019-03-25Quarter388,864k

Equity Trend

ReportDatePeriodType(AKCA)(AKCA)
2017-12-25Quarter-1,112.19%
2018-03-25Quarter-295.22%
2018-06-25Quarter-449.96%
2018-09-25Quarter42.24%
2018-12-25Quarter54.05%
2019-03-25Quarter165.80%

TotalLiability

ReportDatePeriodType(AKCA)(AKCA)
2016-12-25Quarter28,431k
2017-03-25Quarter207,923k
2017-06-25Quarter207,087k
2017-09-25Quarter91,506k
2017-12-25Quarter89,171k
2018-03-25Quarter106,165k
2018-06-25Quarter104,601k
2018-09-25Quarter97,717k
2018-12-25Quarter88,537k
2019-03-25Quarter69,853k

TotalLiability Trend

ReportDatePeriodType(AKCA)(AKCA)
2017-12-25Quarter213.64%
2018-03-25Quarter-48.94%
2018-06-25Quarter-49.49%
2018-09-25Quarter6.79%
2018-12-25Quarter-0.71%
2019-03-25Quarter-34.20%

DebtEquityRatio

ReportDatePeriodType(AKCA)(AKCA)
2016-12-25Quarter-0.6
2017-03-25Quarter-0.4
2017-06-25Quarter-0.4
2017-09-25Quarter2.2
2017-12-25Quarter2.0
2018-03-25Quarter1.4
2018-06-25Quarter2.8
2018-09-25Quarter2.9
2018-12-25Quarter3.1
2019-03-25Quarter5.6

DebtEquityRatio Trend

ReportDatePeriodType(AKCA)(AKCA)
2017-12-25Quarter-422.76%
2018-03-25Quarter-482.78%
2018-06-25Quarter-792.27%
2018-09-25Quarter33.21%
2018-12-25Quarter55.21%
2019-03-25Quarter303.99%

Cash Flow Benchmark | Key Ratio B | Income B | Balance B | Cash B | Top

OperatingCF

ReportDatePeriodType(AKCA)(AKCA)

OperatingCF Trend

ReportDatePeriodType(AKCA)(AKCA)

CAPEX

ReportDatePeriodType(AKCA)(AKCA)

CAPEX Trend

ReportDatePeriodType(AKCA)(AKCA)

FreeCashFlow

ReportDatePeriodType(AKCA)(AKCA)

FreeCashFlow Trend

ReportDatePeriodType(AKCA)(AKCA)

InvestmentFlow

ReportDatePeriodType(AKCA)(AKCA)

InvestmentFlow Trend

ReportDatePeriodType(AKCA)(AKCA)

FinancialFlow

ReportDatePeriodType(AKCA)(AKCA)

FinancialFlow Trend

ReportDatePeriodType(AKCA)(AKCA)

Note